USA, multiple locations - 15 Sep `20Study to Evaluate RECELL and MKTP for Repigmentation of Stable Vitiligo Lesions

Official Title: Multi-Arm Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

In Brief: This is a prospective study to evaluate the application of Spray-On Skin™ Cells, prepared using the RECELL® Device for safe and effective repigmentation of ablated stable vitiligo lesions.

Ages Eligible: 18 Years and older 

Start Date: September 14, 2020

Completion Date (estimated): March 2023

Status: Not yet recruiting

Study ID from ClinicalTrials.gov: NCT04547998
Other Study ID Numbers: CTP009

Locations: CA, CO, FL, MI

Contact: To learn more about this study, you or your doctor may contact 

Elizabeth Kirshner
6613676869
ekirshner@avitamedical.com
 
Lisa Carothers
6614814663
lcarothers@avitamedical.com

Please refer to this study by its NCT number.